The Biotech is pretty flat in the last 7 days, but Pharma Mar has stood out, gaining 4.0%. As for the longer term, the industry has declined 8.0% in the last year. Looking forward, earnings are forecast to grow by 31% annually.
Has the Spanish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 24 Apr 2024 | €5.9b | €6.8b | €58.6m | 99.1x | 99.9x | 0.9x |
Fri, 22 Mar 2024 | €5.7b | €6.8b | €55.1m | 271.8x | 103.6x | 0.8x |
Sun, 18 Feb 2024 | €7.3b | €6.7b | €31.4m | 175.8x | 231.8x | 1.1x |
Tue, 16 Jan 2024 | €6.3b | €6.7b | €31.4m | 154.7x | 199.9x | 0.9x |
Thu, 14 Dec 2023 | €9.2b | €6.7b | €31.4m | 227.4x | 291.7x | 1.4x |
Sat, 11 Nov 2023 | €7.8b | €6.7b | €31.3m | 189.7x | 247.6x | 1.2x |
Mon, 09 Oct 2023 | €7.9b | €6.7b | €23.8m | 493.9x | 330.2x | 1.2x |
Wed, 06 Sep 2023 | €8.3b | €6.7b | €23.8m | 523.4x | 349.5x | 1.2x |
Fri, 04 Aug 2023 | €8.5b | €6.7b | €23.8m | 531.8x | 357.4x | 1.3x |
Sun, 02 Jul 2023 | €7.8b | €6.6b | €69.4m | 94.8x | 112.2x | 1.2x |
Tue, 30 May 2023 | €7.7b | €6.6b | €69.3m | 94.2x | 110.9x | 1.2x |
Thu, 27 Apr 2023 | €6.4b | €6.3b | €251.5m | 22.2x | 25.3x | 1x |
Sat, 25 Mar 2023 | €6.2b | €6.3b | €250.4m | 22.3x | 24.8x | 1x |
Mon, 20 Feb 2023 | €9.7b | €5.5b | €137.1m | 87.5x | 70.7x | 1.8x |
Wed, 18 Jan 2023 | €8.6b | €5.5b | €137.1m | 76.2x | 62.7x | 1.6x |
Fri, 16 Dec 2022 | €7.9b | €5.5b | €137.0m | 68.3x | 57.5x | 1.4x |
Sun, 13 Nov 2022 | €7.6b | €5.5b | €137.8m | 65.2x | 55x | 1.4x |
Tue, 11 Oct 2022 | €6.3b | €5.5b | €136.8m | 54.2x | 46x | 1.2x |
Thu, 08 Sep 2022 | €7.9b | €5.5b | €136.8m | 71.2x | 58x | 1.5x |
Sat, 06 Aug 2022 | €9.5b | €5.5b | €136.8m | 86.7x | 69.3x | 1.7x |
Mon, 04 Jul 2022 | €12.2b | €5.2b | €266.3m | 41.4x | 46x | 2.4x |
Wed, 01 Jun 2022 | €12.8b | €5.2b | €266.5m | 43.5x | 48x | 2.5x |
Fri, 29 Apr 2022 | €11.1b | €5.2b | €268.5m | 37.7x | 41.4x | 2.1x |
Sun, 27 Mar 2022 | €10.4b | €5.2b | €268.5m | 35.3x | 38.7x | 2x |
Tue, 22 Feb 2022 | €9.9b | €5.4b | €720.9m | 15.4x | 13.7x | 1.8x |
Thu, 20 Jan 2022 | €11.2b | €5.4b | €721.8m | 17x | 15.5x | 2.1x |
Sat, 18 Dec 2021 | €10.7b | €5.4b | €721.7m | 16.6x | 14.8x | 2x |
Mon, 15 Nov 2021 | €11.8b | €5.4b | €721.8m | 18.4x | 16.3x | 2.2x |
Wed, 13 Oct 2021 | €12.9b | €5.4b | €729.0m | 19.7x | 17.7x | 2.4x |
Fri, 10 Sep 2021 | €13.5b | €5.4b | €729.0m | 19.7x | 18.5x | 2.5x |
Sun, 08 Aug 2021 | €13.5b | €5.4b | €729.0m | 18.5x | 18.6x | 2.5x |
Sat, 01 May 2021 | €15.4b | €5.5b | €648.5m | 21.4x | 23.7x | 2.8x |
23.7x
Which industries have driven the changes within the Spanish Healthcare industry?
ES Market | 4.83% | |
Healthcare | 0.33% | |
Biotech | 0.15% | |
Biotech | 0.15% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
PHM Pharma Mar | €27.60 | 4.1% +€19.1m | -32.7% | PE428.2x | |
ORY Oryzon Genomics | €2.03 | 5.7% +€6.3m | -3.3% | PB1.5x |